Research study Program year 2022 Source: CMS Open Payments

20-Avp-786-307

Research payments

$596,750

176 payments

Through program year 2022, $596,750 in research payments was reported against 20-Avp-786-307, across 176 payments, paid by Avanir Pharmaceuticals, Inc..

Paid by: Avanir Pharmaceuticals, Inc.
ClinicalTrials.gov: No trial number was reported for this study

By program year

2 rows

Year	Kind	Amount	Payments
2022	Research	$234,048	130
2021	Research	$362,702	46

Breakdown

Who paid Research payments · program years 2021–2022

Avanir Pharmaceuticals, Inc. $596,750 176 payments

Who received the money Research payments · program years 2021–2022

Premier Clinical Research Organisation paid for research $112,878 64 payments
Moonshine Research Center, Inc. Organisation paid for research $84,692 5 payments
Biomed Research Institute, Inc. Organisation paid for research $57,725 10 payments
Velocity Clinical Research, INC Organisation paid for research $42,751 11 payments
Woodland International Research Group, LLC Organisation paid for research $35,143 11 payments
Conquest Research LLC Organisation paid for research $26,380 5 payments
The Feinstein Institute for Medical Research Organisation paid for research $19,803 10 payments
William E. Sanchez, Md, Cpi Organisation paid for research $18,943 3 payments
Dba Neurocare Plus Organisation paid for research $17,975 2 payments
The Research Foundation For The State Of University Of New York Organisation paid for research $15,832 5 payments

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

9 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.